神經診斷市場，依產品類型（腦電圖系統、磁振造影系統、超音波影像系統、電腦斷層掃描儀、試劑和耗材等）、依治療領域、依最終用戶、依地理位置

神經診斷市場預計 2024 年價值為 86.6 億美元，預計到 2031 年將達到 149.1 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 8.1%。

數字。神經診斷市場佔有率 (%)，依地區 2024 年

神經診斷是指透過各種影像和監測技術診斷神經系統疾病。它涉及評估中樞和周圍神經系統是否存在任何異常。由於阿茲海默症、帕金森氏症、癲癇、中風和影響神經系統的各種癌症等神經系統疾病的發生率不斷上升，神經診斷市場在過去幾年中出現了顯著成長。神經影像技術的進步和新型生物標記的開發使得這些疾病的早期、準確診斷成為可能。此外，越來越多的老年人口更容易患神經系統疾病、醫療保健支出增加以及報銷的可及性是預計未來幾年推動神經診斷需求的一些關鍵因素。

市場動態：

全球神經診斷市場主要是由全球神經系統疾病盛行率上升所推動的。根據世界衛生組織（WHO）統計，全球有超過10億人患有神經系統疾病，其中神經和精神疾病佔全球疾病負擔的近10%。先進神經診斷技術的發展也推動了市場的發展，例如磁振造影、超音波掃描儀、電腦斷層掃描儀和正子斷層掃描(PET) 掃描儀，這些技術可提供高解析度影像並有助於準確評估神經結構和功能。然而，創新神經診斷設備和程序的高成本可能會限制市場成長。從積極的一面來看，新興國家不斷成長的醫療保健投資為市場參與者提供了有利可圖的機會。加強遺傳藥理學和個人化醫療領域的研發也預示著預測期內市場的擴張。

研究的主要特點：

• 該報告對全球神經診斷市場進行了深入分析，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
• 它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
• 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
• 它根據以下參數描述了全球神經診斷市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
• 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球神經診斷市場迎合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利害關係人可以透過用於分析全球神經診斷市場的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與假設

• 研究目標
• 假設
• 縮寫

第 2 章：市場範圍

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map (COM)

第 3 章：市場動態、法規與趨勢分析

• 市場動態
  • 促進要素
  • 限制
  • 機會
• 影響分析
• 市場走向
• 最近的發展
• 收購和合作場景
• 產品發布/批准
• 資金和投資
• PEST分析
• 波特的分析

第 4 章：全球神經診斷市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第 5 章：全球神經診斷市場，依產品類型，2019 - 2031 年（十億美元）

• 概述
• 腦電圖 (EEG) 系統
• 磁振造影 (MRI) 系統
• 超音波成像系統
• 電腦斷層掃描 (CT) 掃描儀
• 試劑及耗材
• 其他

第 6 章：全球神經診斷市場，依治療領域，2019 - 2031 年（十億美元）

• 概述
• 神經退化性疾病
• 睡眠障礙
• 中風
• 癲癇
• 其他

第 7 章：全球神經診斷市場，依最終用戶分類，2019 - 2031 年（十億美元）

• 概述
• 醫院
• 診斷中心
• 門診護理中心
• 其他

第 8 章：全球神經診斷市場，依地區分類，2019 - 2031 年（十億美元）

• 介紹
• 北美洲
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 拉丁美洲其他地區
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東協
• 澳洲
• 韓國
• 亞太地區其他地區
• 中東
• 海灣合作理事會
• 以色列
• 中東其他地區
• 非洲
• 北非
• 中非
• 南非

第 9 章：競爭格局

• 公司簡介
  • Koninklijke Philips NV
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

第 10 章：分析師觀點

• 命運之輪
• 分析師觀點
• 連貫的機會圖

第 11 章：參考文獻與研究方法

• 參考
• 研究方法論

The neurodiagnostics market is estimated to be valued at USD 8.66 Bn in 2024 and is expected to reach USD 14.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Figure. Neurodiagnostics Market Share (%), By Region 2024

Neurodiagnostics refers to the diagnosis of neurological disorders through various imaging and monitoring techniques. It involves the evaluation of the central and peripheral nervous system for any abnormalities. The neurodiagnostics market has been witnessing significant growth over the past few years due to the rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and various cancers affecting the nervous system. Advancements in neuroimaging technologies and development of novel biomarkers have enabled the early and accurate diagnosis of these conditions. Furthermore, the growing geriatric population who are more susceptible to neurological diseases, increasing healthcare expenditures, and availability of reimbursement are some of the key factors expected to drive the demand for neurodiagnostics in the coming years

Market Dynamics:

The global neurodiagnostics market is primarily driven by the rising prevalence of neurological disorders worldwide. According to the World Health Organization (WHO), over 1 billion people suffer from neurological disorders globally with neurological and mental disorders accounting for nearly 10% of the global disease burden. The market is also being propelled by the development of advanced neurodiagnostic technologies such as magnetic resonance imaging, ultrasound scanners, computed tomography scanners, and positron emission tomography (PET) scanners which provide high resolution images and aid accurate evaluation of neurological structures and functions. However, the market growth can be restrained by the high cost of innovative neurodiagnostic devices and procedures. On the positive side, growing healthcare investment in emerging nations presents lucrative opportunities for market players. Intensifying R&D in the fields of pharmacogenetics and personalized medicine also bodes well for the market expansion over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global neurodiagnostics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global neurodiagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global neurodiagnostics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurodiagnostics market.

Detailed Segmentation-

• By Product Type:
  • Electroencephalogram (EEG) Systems
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Reagents & Consumables
  • Others
• By Therapeutic Area:
  • Neurodegenerative Diseases
  • Sleep Disorders
  • Stroke
  • Epilepsy
  • Others
• By End User:
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Koninklijke Philips N.V
  • Siemens Healthcare GmbH
  • Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Neurodiagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Neurodiagnostics Market, By Product Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Electroencephalogram (EEG) Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Magnetic Resonance Imaging (MRI) Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ultrasound Imaging Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Computed Tomography (CT) Scanner
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Reagents & Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Neurodiagnostics Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Neurodegenerative Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Sleep Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Stroke
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Epilepsy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Neurodiagnostics Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Neurodiagnostics Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • Koninklijke Philips N.V
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact